Celltrion Cancels Record W1.7 Trillion in Treasury Shares
South Korean biopharmaceutical company Celltrion has announced the cancellation of 9.11 million treasury shares, valued at approximately 1.72 trillion won ($1.1 billion), marking the largest share cancellation in its history.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)Sources
Celltrion retires W1.7tr shares in record cancellation
Celltrion said Wednesday it has canceled 9.11 million treasury shares worth about 1.72 trillion won ($1.1 billion), marking the largest share cancellation in its history. The move, approved by the board, accounts for roughly 4 percent of the company’s outstanding shares and exceeds the combined 1.6 trillion won in share cancellations carried out in 2024 and 2025. The canceled shares include 3 million previously reserved for employee stock option programs, underscoring Celltrion’s focus on enhanc
By The Korea Herald
Read full article →Celltrion to cancel 1.72 tln won in treasury shares to boost shareholder value - Yonhap News Agency
Celltrion to cancel 1.72 tln won in treasury shares to boost shareholder value Yonhap News Agency
Read full article →
